ReviewThe Clinical biochemist. Reviews2010
The Evidence to Support Point-of-Care Testing.
Review in The Clinical biochemist. Reviews, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed.
- Regulation and governance for the implementation and management of point-of-care testing in Australia: a scoping review.BMC public health · 2025Article
- Scaling up hepatitis C testing and linkage-to-care among people who use drugs: lessons learned from a pilot project implemented at a supervised consumption site.BMC health services research · 2025Article
- Barriers, enablers, benefits, and drawbacks to point-of-care testing: a survey of the general practice out-of-hours service in Scotland.BJGP open · 2024Article
- Point-of-care testing preferences 2020-2022: Trends over the years.Cardiovascular digital health journal · 2024Article
- Primary Technology Enhanced Care Home HbA1c Testing (PTEC HAT) programme: a feasibility pilot study in Singapore.BMC primary care · 2024Article
- Neglected tropical disease (NTD) diagnostics: current development and operations to advance control.Pathogens and global health · 2024Review
- How Can Point-of-Care Technologies Support In-Hospital Diabetes Care?Journal of diabetes science and technology · 2023Article
- Label-free multiplex electrochemical immunosensor for early diagnosis of lysosomal storage disorders.Scientific reports · 2022Article
- Diagnosing point-of-care diagnostics for neglected tropical diseases.PLoS neglected tropical diseases · 2021Review
- Review
- The Impact of Point-of-Care Hemoglobin A1c Testing on Population Health-Based Onsite Testing Adherence: A Primary-Care Quality Improvement Study.Journal of diabetes science and technology · 2021Article
- Carbohydrate binding module-fused antibodies improve the performance of cellulose-based lateral flow immunoassays.Scientific reports · 2021Article
- Quantum Dots: An Emerging Tool for Point-of-Care Testing.Micromachines · 2020Review
- The challenge of producing an EQA for the COVID-19 pandemic.Practical laboratory medicine · 2020Article
- Efficacy of Point-of-Care for INR Testing Compared to Standard Laboratory Methods at a Tertiary Care Hospital in Saudi Arabia.Global journal on quality and safety in healthcare · 2020Article
- Clinical Validation of Integrated Point-of-Care Devices for the Management of Non-Communicable Diseases.Diagnostics (Basel, Switzerland) · 2020Article
- Perspectives On Blood-Based Point-Of-Care Diagnostics.Open access emergency medicine : OAEM · 2019Article
- Approaches to the assessment of severe asthma: barriers and strategies.Journal of asthma and allergy · 2019Article
- Development of point-of-care testing devices to improve clozapine prescribing habits and patient outcomes.Neuropsychiatric disease and treatment · 2019Article
- Protocol for a cluster randomized controlled trial to study the effectiveness of an obesity and diabetes intervention (PASOS) in an immigrant farmworker population.BMC public health · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Point-of-care testing (PoCT) is now possible in many areas of clinical medicine. This review examines the evidence for its application in four areas: self-monitoring; community testing primarily in the pharmacy; general practice; and the emergency department. In all of these areas except pharmacy, randomised controlled trials of PoCT versus central laboratory testing have been performed, with the results of some of these trials supporting the use of PoCT. Aside from providing evidence, these trials and other observational studies have provided valuable information about how PoCT should be conducted. In particular they have shown that adoption of the technology is often insufficient to achieve a benefit and in some cases a change of care process is also required.
Identifiers
24150515PMC2924123What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.